BSE filing, NSE: BLISSGVS. Summary written from the filing by ALFA Finder's alert engine.
Bliss GVS Pharma Ltd: key numbers
- Share price
- ₹648.50
- Market cap
- ₹6,899 Cr
- Revenue (annual)
- ₹927.1 Cr
- Net profit (annual)
- ₹129.1 Cr
- P/E (TTM)
- 50.7×Sector 46.1×
- Promoter holding
- 50.07%+15.06% QoQ
- FII holding
- 5.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bliss GVS Pharma Ltd
All →Bliss GVS Pharma Board Meeting Date
Bliss GVS Pharma Ltd scheduled a board meeting for October 29, 2026, to approve the company's unaudited financial results for the quarter ending September 30, 2026.
Bliss GVS Pharma Other Announcement
Bliss GVS Pharma Ltd has filed its quarterly shareholding pattern report for the period ended September 30, 2026.
Bliss GVS Pharma Annual General Meeting
Bliss GVS Pharma has issued a postal ballot notice to seek member approval for the appointment of three directors. This follows a recent change in control.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma Limited allotted 53,500 equity shares under its Employee Stock Option Plan (ESOP). This issuance increases the company's total paid-up share capital.
Bliss GVS Pharma Promoter Reclassification
Bliss GVS Pharma announced the reclassification of its erstwhile promoter group to the public category following a change in control via an open offer.
Bliss GVS Pharma Share Pledge
Promoter Mates Visa Consultancy pledged 5.1 crore shares of Bliss GVS Pharma valued at ₹3,487.35 Crore. This pledge creates leverage on the promoter's stake.
- Value
- ₹3,487 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date
V-Guard Industries Employee Stock Options
V-Guard's committee approved a grant of 16,747 ESOS 2013 options on October 28, 2026. Options vest over up to four years, with a ₹1 exercise price.